AMICUS THERAPEUTICS, INC.·4

Jan 9, 6:07 PM ET

Prout Samantha 4

4 · AMICUS THERAPEUTICS, INC. · Filed Jan 9, 2024

Insider Transaction Report

Form 4
Period: 2024-01-08
Prout Samantha
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2024-01-09$14.00/sh1,337$18,71880,953 total
  • Sale

    Common Stock

    2024-01-08$14.00/sh30,767$430,82782,290 total
Footnotes (1)
  • [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.03 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4